Rachael Lester
Chief Business Officer & Senior VPMs. Rachael Lester is Chief Business Officer & Senior VP of CytomX Therapeutics, Inc since October 10, 2025. In this role, Ms. Lester lead the Company???s strategy and business development functions. Ms. Lester joins CytomX with over two decades leading corporate strategy, business development and product portfolio planning across the life science and biopharmaceutical industry. Ms. Lester served as Chief Business Officer at Replicate Bioscience, Inc. since July 2023. She has an experience as a senior executive in the biopharmaceutical industry and is responsible for leading corporate strategy, business development, portfolio strategy and new product planning. She served as Senior Vice President of Business Development and Corporate Strategy at Harpoon Therapeutics, Inc. since July 2021. and also served as Vice President of Corporate Development since October 26, 2017 until July 2021. Ms. Lester served as Vice President of Product & Marketing at Bruin Biometrics, LLC until October 2017, where she led the commercialization of SEM Scanner® and drove ongoing R&D collaborations and Partnerships. With various roles in Marketing, R&D and Finance, she has launched over 6 new biopharmaceutical and medical device products. She served as Global Head of Strategic Asset Management at Onyx Pharmaceuticals. She was responsible for portfolio management, strategic finance and various corporate strategy and development initiatives through the sale to Amgen. She has held Marketing roles at Pfizer and was a management consultant at Deloitte Consulting, where she served as the West Coast lead for Life Sciences Commercial Strategy & Operations. She received her MBA from Kellogg School of Management and B.A. in neuroscience from the University of Pennsylvania.
Positions
- Company NameCytomX Therapeutics, Inc.Stock CodeCTMXPositionChief Business Officer & Senior VPColleagues
- SASean A. McCarthyChairman & CEO
- CWChristopher W. OgdenSVP, CFO & Secretary
- MPMarcia P. BelvinSenior VP & Chief Scientific Officer
- AVAlejandra Veronica CarvajalChief Legal Officer
- MPMatthew P. YoungLead Independent Director
- JRJames R. MeyersIndependent Director
- HEHalley E. GilbertIndependent Director
- WMW. Michael KavanaughMember of Scientific Advisory Board
